National

FabiFlu: India's first COVID-19 drug launched, priced at Rs 103 per tablet

FabiFlu: Finally, the much awaited COVID-19 medicine launched in India.

Pharmaceutical company Glenmark Pharmaceuticals, under the brand name FabiFlu, has finally launched an antiviral drug Favipiravir, to cure patients with mild to moderate coronavirus at a price tag of about Rs 103 per tablet.

As per the Pharmaceutical firm, the medication will be available in the form of a 200 mg tablet and will be at a maximum retail price (MRP) of Rs 3,500 for a strip of 34 tablets.

Etihad Airways to start special passenger flights to Abu Dhabi between July 12-26

New Delhi: Etihad Airways on Friday announced it will operate a limited number of special flights from six Indian cities to Abu Dhabi in the UAE betwe...

Nadda discussed upcoming party events with state officials, MPs via video conferencing

New Delhi : Bharatiya Janata Party (BJP) president Jagat Prakash Nadda on Friday discussed a number of topics including the upcoming events of the par...

Kanpur encounter main accused Vikas Dubey killed: UP Police

Kanpur (Uttar Pradesh): Kanpur encounter main accused Vikas Dubey, who was injured in an encounter with the police, died on Friday, the police said."G...

COVID-19 recovery rate in India at 63 pc, mortality rate at 2.72 pc: Harsh Vardhan

New Delhi: Union Health Minister Harsh Vardhan on Friday said the recovery rate of COVID-19 patients in India currently stands at about 63 per cent an...